Marcia Moura Schmidt, Alexandre Schaan de Quadros, Eduarda Schütz Martinelli, Carlos Antonio Mascia Gottschall
Selección de pacientes para balones liberadores de droga: Infarto agudo del miocardio, vasos pequeños, pacientes diabéticos Dr. Ron Waksman – Washington Hospital Center – Estados Unidos
Selección de pacientes para balones liberadores de droga: Infarto agudo del miocardio, vasos pequeños, pacientes diabéticos Dr. Ron Waksman – Washington Hospital Center – Estados Unidos
Caracterización Morfológica y Tisular de Lesiones Culpables en Pacientes con Infarto Agudo de Miocardio con Elevación del Segmento ST Después del Uso de Fibrinolítico. Análisis con Ultrasonido Intracoronario y Tecnología iMAP®
Cristiano Freitas de Souza, Akiko Maehara, Eduardo Lima, Leonardo de Freitas C. Guimarães, Antonio Carlos Carvalho, Claudia M.R. Alves, Adriano Caixeta
¿La Inhibición de la Vía Final Común de la Agregación Plaquetaria Reduce el Fenómeno de no-reflow Durante la Intervención Coronaria Percutánea Primaria? Tirofiban en el Infarto Agudo de Miocardio y la no Reperfusión (TIARA)
Igor Matos Lago, J. Antonio Marin-Neto, Moysés de Oliveira Lima-Filho, Antonio Pazin Filho, Geraldo Luiz Figueiredo, Jorge Luis Haddad, Roberto Botelho, Ricardo Barbosa, Ulisses Marques Gianechini, Breno de Siqueira
Impacto de la insuficiencia renal aguda en la evolución hospitalaria luego del tratamiento percutáneo de infarto agudo de miocardio
Luciano Nunes dos Santos, Fábio Conejo, Francisco Hedilberto Feitosa Filho, Carlos Augusto Homem de Magalhães Campos, J. Mariani Junior, Celso Kiyochi Takimura, Antônio Esteves Filho, Expedito Eustáquio Ribeiro da Silva, Roberto Kalil Filho, Pedro Alv
Artículo original: Evolución Hospitalaria de Pacientes con Choque Cardiogénico por Infarto Agudo de Miocardio con Supradesnivel del Segmento ST
Francisco Hedilberto Feitosa Filho, Fabio Conejo, Luciano Nunes dos Santos, Carlos Augusto Campos, Pedro Alves Lemos Neto
Infarto Agudo del Miocardio en Pacientes Octogenarios
Gustavo Vignolo2012-11-23
Non-ST Elevation MI: How Long Do We Have for A Coronary Angiography?
This summary discusses the early invasive strategy and the risk of mortality in non-ST-elevation AMI. Over the past 2 decades, mortality and complications rates have seen a significant reduction thanks to technological and pharmaceutical development, and the increasing experience of health teams. This is especially true when we look at the use of coronary angiography<a href="https://solaci.org/en/2023/01/20/non-st-elevation-mi-how-long-do-we-have-for-a-coronary-angiography/" title="Read more" >...</a>
Initial Complete Revascularization vs. Staged Revascularization in Patients with STEMI and Multivessel Disease
In patients with ST-segment elevation acute myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (primary PCI), multivessel disease is observed in up to 40% of cases. The optimal timing for revascularizing non-culprit lesions in these patients without cardiogenic shock remains a controversial issue. European guidelines recommend completing revascularization during the initial procedure or within 45 days<a href="https://solaci.org/en/2024/07/17/initial-complete-revascularization-vs-staged-revascularization-in-patients-with-stemi-and-multivessel-disease/" title="Read more" >...</a>
Revascularization Timing in Acute Coronary Syndrome
Multivessel disease is often present in ST elevation acute myocardial infarction (STEMI) patients. The AHA/ACC 2021 revascularization guidelines recommend staged complete revascularization as class I, single-setting complete revascularization as class 2b, and recommend against culprit only revascularization. At present, we have more randomized studies (BIOVASC, FIRE and MULTISTAR) comparing staged vs single-setting complete revascularization, but<a href="https://solaci.org/en/2024/07/16/revascularization-timing-in-acute-coronary-syndrome/" title="Read more" >...</a>